Cargando…

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes

Chronic hepatitis B, C, and D virus (HBV, HCV, and HDV) infections are the leading causes of liver disease and cancer worldwide. Recently, the solute carrier and sodium taurocholate co-transporter NTCP has been identified as a receptor for HBV and HDV. Here, we uncover NTCP as a host factor regulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verrier, Eloi R., Colpitts, Che C., Bach, Charlotte, Heydmann, Laura, Zona, Laetitia, Xiao, Fei, Thumann, Christine, Crouchet, Emilie, Gaudin, Raphaël, Sureau, Camille, Cosset, François-Loïc, McKeating, Jane A., Pessaux, Patrick, Hoshida, Yujin, Schuster, Catherine, Zeisel, Mirjam B., Baumert, Thomas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098118/ https://www.ncbi.nlm.nih.gov/pubmed/27783949 http://dx.doi.org/10.1016/j.celrep.2016.09.084

Ejemplares similares

Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets
por: Verrier, Eloi R, et al.
Publicado: (2020)

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection
por: Verrier, Eloi R., et al.
Publicado: (2016)

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape
por: Colpitts, Che C, et al.
Publicado: (2018)

A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor
por: Eller, Carla, et al.
Publicado: (2020)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

Hepatitis B virus compartmentalization and single-cell differentiation in hepatocellular carcinoma
por: Jühling, Frank, et al.
Publicado: (2021)

Host-targeting therapies for hepatitis C virus infection: current developments and future applications
por: Crouchet, Emilie, et al.
Publicado: (2018)

CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies
por: Zona, Laetitia, et al.
Publicado: (2014)

Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux
por: Crouchet, Emilie, et al.
Publicado: (2017)

A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission
por: Fofana, Isabel, et al.
Publicado: (2013)

Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes
por: Yan, Ran, et al.
Publicado: (2015)

Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target
por: Verrier, Eloi R, et al.
Publicado: (2023)

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
por: Wrensch, Florian, et al.
Publicado: (2018)

N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection
por: Appelman, Monique D., et al.
Publicado: (2017)

Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells
por: Li, Xinlei, et al.
Publicado: (2021)

Liver cell circuits and therapeutic discovery for advanced liver disease and cancer
por: Crouchet, Emilie, et al.
Publicado: (2021)

Primary hepatocytes as targets for Hepatitis C virus replication
por: Farquhar, M J, et al.
Publicado: (2008)

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
por: Jühling, Frank, et al.
Publicado: (2021)

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
por: Baumert, Thomas F., et al.
Publicado: (2019)

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
por: Hamdane, Nourdine, et al.
Publicado: (2019)

Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection
por: Fafi-Kremer, Samira, et al.
Publicado: (2012)

Targeting the Host for New Therapeutic Perspectives in Hepatitis D
por: Turon-Lagot, Vincent, et al.
Publicado: (2020)

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process
por: Colpitts, Che C., et al.
Publicado: (2020)

Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection
por: Yan, Ying, et al.
Publicado: (2019)

Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
por: Xiao, Fei, et al.
Publicado: (2014)

Unlocking the secrets to human NTCP structure
por: Qi, Xiangbing, et al.
Publicado: (2022)

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
por: Shimura, Satomi, et al.
Publicado: (2017)

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies
por: Duong, Francois H.T., et al.
Publicado: (2014)

Targeting Viral cccDNA for Cure of Chronic Hepatitis B
por: Ligat, Gaëtan, et al.
Publicado: (2020)

Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection
por: Heuschkel, Margaux J., et al.
Publicado: (2021)

hNTCP-expressing primary pig hepatocytes are a valuable tool for investigating hepatitis B virus infection and antiviral drugs
por: Zhou, Ming, et al.
Publicado: (2019)

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
por: Baumert, Thomas F., et al.
Publicado: (2017)

Mechanistic insights into the inhibition of NTCP by myrcludex B
por: Donkers, Joanne M., et al.
Publicado: (2019)

Insufficient evidence for NTCP activity in stellate cells
por: Kunst, Roni F, et al.
Publicado: (2022)

Hepatitis B virus–host interactions and novel targets for viral cure
por: Ligat, Gaëtan, et al.
Publicado: (2021)

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
por: Roehlen, Natascha, et al.
Publicado: (2020)

Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infection†
por: Crouchet, E., et al.
Publicado: (2017)

Polymorphisms within DIO2 and GADD45A genes increase the risk of liver disease progression in chronic hepatitis b carriers
por: Rybicka, Magda, et al.
Publicado: (2023)

NTCP deficiency in mice protects against obesity and hepatosteatosis
por: Donkers, Joanne M., et al.
Publicado: (2019)

In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?
por: Giersch, Katja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lsrjnvral4pupmf3dnk7tmv8i1